| 产品名称: |
terlipressin |
| 规格或纯度: |
Moligand™ |
| 作用类型: |
结合剂 |
| 作用机制: |
血管加压素 V2 受体结合剂 |
| 靶点: |
Vasopressin V1 receptor;VasopressinReceptor |
| 体内研究: |
Using a mouse nonlethal hepatic ischemia-reperfusion (IR) model, Terlipressin administration significantly ameliorates IR-induced liver apoptosis, necrosis and inflammation |
| 参考文献: |
1. Zi-Meng Liu, et al. Terlipressin Protects Intestinal Epithelial Cells Against Oxygen-Glucose Deprivation/Re-Oxygenation Injury via the Phosphatidylinositol 3-kinase Pathway. Exp Ther Med. 2017 Jul;14(1):260-266. 2. Yeun Tarl Fresner Ng Jao, et al. Refractory Torsade De Pointes Induced by Terlipressin (Glypressin). Int J Cardiol. 2016 Nov 1;222:135-140. 3. Xiqiang Liu, et al. Signaling Through Hepatocyte Vasopressin Receptor 1 Protects Mouse Liver From Ischemia-Reperfusion Injury. Oncotarget. 2016 Oct 25;7(43):69276-69290. 4. Xinmiao Zhou, et al. Terlipressin for the Treatment of Acute Variceal Bleeding: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2018 Nov;97(48):e13437. 5. Alastair O'Brien, et al. Terlipressin for Norepinephrine-Resistant Septic Shock. Lancet. 2002 Apr 6;359(9313):1209-10. |
| 溶解性: |
DMSO : 100 mg/mL (81.48 mM; Need ultrasonic) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0.815 ml |
4.074 ml |
8.148 ml |
| 5 mM |
0.163 ml |
0.815 ml |
1.63 ml |
| 10 mM |
0.081 ml |
0.407 ml |
0.815 ml |
| 50 mM |
0.016 ml |
0.081 ml |
0.163 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |